ArticleThe Journal of pharmacology and experimental therapeutics2010

The novel pyrrolidine nor-lobelane analog UKCP-110 [cis-2,5-di-(2-phenethyl)-pyrrolidine hydrochloride] inhibits VMAT2 function, methamphetamine-evoked dopamine release, and methamphetamine self-administration in rats.

Joshua S Beckmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.